Joseph Shulman, Chief Technical Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 31,030 shares at $39.22 ($1.2M) on 2024-03-19, disclosed to the SEC on 2024-03-19.
Open-market sale of $1.2M RYTM by Chief Technical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.22 | 15,515 | $608K | 50.0% |
| 2 | $39.22 | 15,515 | $608K | 50.0% |
| Total | $39.22 avg | 31,030 | $1.2M | 100% |
| Filing → |
| RYTM | SELL | 2025-10-30 | $648K | — | Filing → |
| RYTM | SELL | 2025-10-20 | $3.2M | — | Filing → |
| RYTM | SELL | 2025-09-04 | $3.5M | — | Filing → |